TER 286: Clinical Trials

5 trials of TER 286, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 25Completed 5

Follow TER 286: new trials by email Literature Review of TER 286 trials Research Report on TER 286

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
TLK286, carboplatin, paclitaxel - Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2CompletedTelik1002004-08-012012-05-31
TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
TLK286, cisplatin - Non-small Cell Lung Cancer
Phase 1 / Phase 2CompletedTelik502004-02-012011-07-25
TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer
TLK286 - Ovarian Neoplasms
Phase 1 / Phase 2CompletedTelik282003-02-012011-07-25
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
TLK286 - Ovarian Neoplasms
Phase 1 / Phase 2CompletedTelik282003-01-012011-07-25
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer
TLK286 in combination with docetaxel - Carcinoma, Non-small-cell Lung
Phase 1 / Phase 2CompletedTelik282002-10-012011-07-25

Conditions studied

Carcinoma, Non-Small-Cell Lung (3)  ·  Ovarian Neoplasms (2)

Sponsors

Telik (5)

Countries

United States (5)

Results publications

PMID 20222977